Adverse effect of dopamine agonist therapy in a patient with motor- intentional neglect

Archives of Physical Medicine and Rehabilitation

Volumn 80, Issue 5, 1999, Pages 600-603

  Barrett, Anna M ^a,c   Crucian, Gregory P ^a   Schwartz, Ronald L ^b   Heilman, Kenneth M ^a,c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; ARTICLE; BRAIN INFARCTION; CASE REPORT; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; HUMAN; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR DYSFUNCTION; NEGLECT; NUCLEAR MAGNETIC RESONANCE IMAGING; RIGHT HEMISPHERE; STROKE; TREATMENT FAILURE;

EID: 0032922223     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(99)90205-8     Document Type: Article

References (21)

1. Heilman KM, Watson RT, Valenstein E. Neglect and related disorders. In: Heilman KM, Valenstein E, editors. Clinical neuropsychology. New York: Oxford University Press; 1993. p. 279-336.
2. Mesulam M-M. Attention, confusional states, and neglect. In: Mesulam M-M, editor. Principles of behavioral neurology. Philadelphia (PA): FA Davis; 1985, p. 125-68.
3. Fleet WS, Valenstein E, Watson RT, Heilman KM. Dopamine agonist therapy for neglect in humans. Neurology 1987;37: 1765-70.
4. Deuel RK, Collins RC. Recovery from unilateral neglect. Exp Neurol 1983;81:733-48.
5. Feeney DM, Sutton RL. Pharmacotherapy for recovery of function after brain injury. Crit Rev Neurobiol 1987;3:135-97.
6. Corwin JV, Kanter S, Watson RT, Heilman KM, Valenstein E, Hashimoto A. Apomorphine has a therapeutic effect on neglect produced by unilateral dorsomedial prefrontal cortex lesions in rats. Exp Neurol 1986;94:683-98.
7. McNeny R, Zasler ND. Neuropharmacologic management of hemi-inattention after brain injury. Neurol Rehabil 1991;1:72-8.
8. Whyte J. Neurologic disorders of attention and arousal: assessment and treatment. Arch Phys Med Rehabil 1992;73:1094-103.
9. Hurford P, Stringer AY, Jann B. Neuropharmacologic treatment of hemineglect: a case report comparing bromocriptine and methylphenidate. Arch Phys Med Rehabil 1998;79:346-9.
10. Ross ED, Stewart RM, Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists. Neurology 1981;31:1435-9.
11. Anderson B. Relief of akinetic mutism from obstructive hydrocephalus using bromocriptine and ephedrine. J Neurosurg 1992;76: 152-5.
12. Benton AL, Hamsher KdeS. Multilingual aphasia examination. Iowa City (IA): AJA Associates; 1989.
13. Albert ML. A simple test of visual neglect. Neurology 1973;23: 658-64.
14. Na DL, Adair JC, Williamson DJ, Schwartz RL, Haws B, Heilman KM. Dissociation of sensory-attentional from motor-intentional neglect. J Neurol Neurosurg Psychiatry 1998;64:331-8.
15. Campbell DC, Oxbury JM. Recovery from unilateral visuo-spatial neglect? Cortex 1976;12:303-12.
16. Wade DT, Wood VA, Hewer RL. Recovery of cognitive function soon after stroke: a study of visual neglect, attention span and verbal recall. J Neurol Neurosurg Psychiatry 1988;51:10-3.
17. Diller L, Weinberg J. Hemi-inattention in rehabilitation: the evolution of a rational remediation program. In: Weinstein EA, Friedland RR, editors. Advances in neurology, Vol 18. New York: Raven Press; 1997. p. 63-82.
18. Müller U, von Cramon DY. The therapeutic potential of bromocriptine in neuropsychological rehabilitation of patients with acquired brain damage. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18:1103-20.
19. Avemo A, Antelman S, Ungerstedt U. Rotational behavior after unilateral frontal cortex lesions in the rat [abstract]. Acta Physiol Scand Suppl 1973;396:77.
20. Jones TA, Schallen T. Use-dependent growth of pyramidal neurons after neocortical damage. J Neurosci 1994;14:2140-52.
21. Barrett K. Treating organic abulia with bromocriptine and lisuride: four case studies. J Neurol Neurosurg Psychiatry 1991;54:718-21.